Sign in
GRNA Stock Price, Chart, Stats & News
GreenLight Biosciences Holdings
Save
45.43M
Market cap
–
Current P/E
–
Forward P/E
GRNA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -2567.65% |
Pretax margin | -2599.67% |
Net margin | -2616.78% |
Effective tax rate | -0.66% |
ROA | -112.42% |
ROE | -1847.24% |
D/E | 1.67x |
Interest coverage ratio | -39.76x |
GRNA valuation
P/E | – |
P/S | 7.12x |
P/B | 0.82x |
P/CF | -0.29x |
P/FCF | -0.28x |
P/OCF | -0.29x |
PEG | -0.00x |
EV multiple | -0.21x |
About
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops.
Similar securities
Based on sector and market capitalization
Report issue